Meng Li1, Yuan Wan1, Li Zhang1, Li-Na Zhou1, Zhuo Shi1, Rui Zhang1, Yan-Lei Hou1, Ning Wu1,2. 1. Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. 2. PET-CT Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Abstract
BACKGROUND: Multifocal ground glass nodules (GGNs) represent a special radiological pattern indicative of synchronous multiple lung cancers (SMLCs), especially adenocarcinoma. However, the necessity of performing whole-body positron emission tomography/computed tomography (PET-CT) scanning and brain enhanced magnetic resonance imaging (MRI) as a staging workup for multifocal pure GGN (pGGN) patients remains unclear. The purpose of this study was to determine the utility of these two imaging scans for patients with multifocal pGGNs. METHODS: This retrospective study was reviewed and approved by the ethics committee of the Cancer Hospital of the Chinese Academy of Medical Sciences. The study cohort was retrospectively selected from patients with multifocal pGGNs who underwent whole-body PET-CT examinations and/or brain enhanced MRIs between January 2010 and February 2019 at our institution. The additional value of the two exams for detecting nodal and distant metastases was evaluated. RESULTS: In total, 73 patients (male-to-female ratio, 20:53; median age, 57 years) with multifocal pGGNs who underwent whole-body PET-CT (55 patients) and/or brain enhanced MRI (25 patients) were enrolled. No clearly metastatic lesions were detected. Among the enrolled patients, 53 (128 pGGNs) underwent complete surgical resection. All pGGNs were adenocarcinomas and/or preneoplasias, and no lymph node metastases were found on final pathology. Whole-body PET-CT and brain enhanced MRI added no definite benefit compared with chest CT alone before surgery. CONCLUSIONS: Whole-body PET-CT scans and brain enhanced MRIs are not necessary for patients with multifocal pGGNs. 2019 Translational Lung Cancer Research. All rights reserved.
BACKGROUND: Multifocal ground glass nodules (GGNs) represent a special radiological pattern indicative of synchronous multiple lung cancers (SMLCs), especially adenocarcinoma. However, the necessity of performing whole-body positron emission tomography/computed tomography (PET-CT) scanning and brain enhanced magnetic resonance imaging (MRI) as a staging workup for multifocal pure GGN (pGGN) patients remains unclear. The purpose of this study was to determine the utility of these two imaging scans for patients with multifocal pGGNs. METHODS: This retrospective study was reviewed and approved by the ethics committee of the Cancer Hospital of the Chinese Academy of Medical Sciences. The study cohort was retrospectively selected from patients with multifocal pGGNs who underwent whole-body PET-CT examinations and/or brain enhanced MRIs between January 2010 and February 2019 at our institution. The additional value of the two exams for detecting nodal and distant metastases was evaluated. RESULTS: In total, 73 patients (male-to-female ratio, 20:53; median age, 57 years) with multifocal pGGNs who underwent whole-body PET-CT (55 patients) and/or brain enhanced MRI (25 patients) were enrolled. No clearly metastatic lesions were detected. Among the enrolled patients, 53 (128 pGGNs) underwent complete surgical resection. All pGGNs were adenocarcinomas and/or preneoplasias, and no lymph node metastases were found on final pathology. Whole-body PET-CT and brain enhanced MRI added no definite benefit compared with chest CT alone before surgery. CONCLUSIONS: Whole-body PET-CT scans and brain enhanced MRIs are not necessary for patients with multifocal pGGNs. 2019 Translational Lung Cancer Research. All rights reserved.
Authors: Roy A Raad; James Suh; Saul Harari; David P Naidich; Maria Shiau; Jane P Ko Journal: Radiol Clin North Am Date: 2013-10-06 Impact factor: 2.303
Authors: M K Ferguson; T R DeMeester; J DesLauriers; A G Little; M Piraux; H Golomb Journal: J Thorac Cardiovasc Surg Date: 1985-03 Impact factor: 5.209
Authors: Xiaoyan Wang; Mingsheng Wang; Gregory T MacLennan; Fadi W Abdul-Karim; John N Eble; Timothy D Jones; Felix Olobatuyi; Rosana Eisenberg; Oscar W Cummings; Shaobo Zhang; Antonio Lopez-Beltran; Rodolfo Montironi; Suqin Zheng; Haiqun Lin; Darrell D Davidson; Liang Cheng Journal: J Natl Cancer Inst Date: 2009-04-07 Impact factor: 13.506
Authors: Frank C Detterbeck; Edith M Marom; Douglas A Arenberg; Wilbur A Franklin; Andrew G Nicholson; William D Travis; Nicolas Girard; Peter J Mazzone; Jessica S Donington; Lynn T Tanoue; Valerie W Rusch; Hisao Asamura; Ramón Rami-Porta Journal: J Thorac Oncol Date: 2016-03-03 Impact factor: 15.609
Authors: Ho Yun Lee; Kyung Soo Lee; Byung-Tae Kim; Young-Seok Cho; Eun Jeong Lee; Chin A Yi; Myung Jin Chung; Tae Sung Kim; O Jung Kwon; Hojoong Kim Journal: J Korean Med Sci Date: 2009-11-09 Impact factor: 2.153
Authors: Kai Qian; Yi Deng; William S Krimsky; Yong-Geng Feng; Jun Peng; Yong-Hang Tai; Hao Peng; Li-Hong Jiang Journal: Front Oncol Date: 2022-04-12 Impact factor: 5.738